Drupal.behaviors.print = function(context) {window.print();window.close();}>
Cancer Genetics Partners with Gilead on CLL Clinical Trials; Revises Expected Proceeds from IPO
March 12, 2013
Cancer Genetics Partners with Gilead on CLL Clinical Trials; Revises Expected Proceeds from IPO
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Cancer Genetics Prices IPO; Expects $6M in Proceeds
April 5, 2013 / GenomeWeb Daily News
Cancer Genetics Plans $48.6M IPO
May 14, 2012 / GenomeWeb Daily News
Cancer Genetics Inks Deal with MultiPlan for Access to Tests, Services
May 21, 2013 / GenomeWeb Daily News
NanoString Technologies Files to Go Public
May 20, 2013 / GenomeWeb Daily News
Underwriters Exercise Over-allotment Option on Cancer Genetics IPO
April 8, 2013 / GenomeWeb Daily News